COMMUNIQUÉS West-GlobeNewswire

Endocyte Appoints Patrick Machado, J.D. to Its Board of Directors

27/02/2018 - 22:01

– Patrick Machado, Co-founder and Former Chief Business and Financial Officer of Medivation, Brings Significant Experience in Building Value in the Prostate Cancer Space – WEST LAFAYETTE, Ind., Feb. 27, 2018 (GLOBE [...]

MannKind Corporation Reports 2017 Fourth Quarter and Full Year Financial Results

27/02/2018 - 22:01

Q4 and 2H 2017 Afrezza net revenue were $4.5 million (+238%) and $6.4 million (+240%) vs. 2016, respectively Q4 and 2H 2017 net cash used in operating activities were $30.0 million and $53.3 million, respectively Cash [...]

MacroGenics Provides Update on Corporate Progress and 2017 Financial Results

27/02/2018 - 22:01

ROCKVILLE, Md., Feb. 27, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX ), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]

Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and Results

27/02/2018 - 22:01

CAMBRIDGE, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, March 6th, 2018, [...]

Amicus Therapeutics Launches Healing Beyond Disease™ Initiatives to Change People’s Lives Living with Rare Diseases

27/02/2018 - 22:01

CRANBURY, N.J., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD ) is honoring Rare Disease Day this week with the launch of Healing Beyond Disease™, a global, Amicus employee-driven initiative [...]

Gemphire Expert Panel Call on Pediatric Nonalcoholic Fatty Liver Disease (NAFLD) and NASH to be Rescheduled

27/02/2018 - 22:01

LIVONIA, Mich., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Pledge to #EndTheStigma on Mental Health with assessURhealth™ at HIMSS18

27/02/2018 - 21:10

Tampa, FL, Feb. 27, 2018 (GLOBE NEWSWIRE) -- assessURhealth, LLC brings its mental and behavioral health screening tool to the exhibit floor for the 2018 HIMSS Conference & Exhibition at the Sands Convention Center [...]

Adventist Health Selects Michelle Fuentes to Lead Adventist Health Sonora

27/02/2018 - 21:00

ROSEVILLE, Calif., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Adventist Health —a faith-based, nonprofit integrated health system serving more than 75 communities in California, Oregon and Hawaii—today announced the appointment [...]

Health Quality Council of Alberta seeks voice of Albertans to improve healthcare quality

27/02/2018 - 20:43

CALGARY, Alberta, Feb. 27, 2018 (GLOBE NEWSWIRE) -- The Health Quality Council of Alberta (HQCA) is looking for Albertans to join its Patient and Family Advisory Committee to bring the patient and family perspective to [...]

Atrion Corporation Declares Quarterly Cash Dividend

27/02/2018 - 20:31

ALLEN, Texas, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (NASDAQ: ATRI ) today announced that its Board of Directors declared a quarterly dividend of $1.20 per share on its outstanding shares of Common Stock. [...]

Vital® to Showcase Enhancements to the Vitrea® Enterprise Imaging Solution at HIMSS 2018

27/02/2018 - 19:45

MINNETONKA, Minn., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Vital Images, Inc., will feature the latest developments within its powerful Vitrea Enterprise Imaging solution at HIMSS 2018, in booth 843, March 5-9, in Las Vegas, [...]

Micron Solutions, Inc. Announces Multi-Year Exclusive Manufacturing Agreement with its Largest Customer

27/02/2018 - 18:21

FITCHBURG, Mass., Feb. 27, 2018 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (the “Company”) (NYSE American:MICR) is pleased to announce that its wholly owned subsidiary Micron Products, Inc. (“Micron”) with offices in [...]

Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU)

27/02/2018 - 18:00

Helsinn Group announces the appointment of Paul Rittman as Chief Executive Officer, Helsinn Therapeutics (HTU) Lugano, Switzerland February 27, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality [...]

Dentsply Sirona to Report Fourth Quarter and Fiscal 2017 Results

27/02/2018 - 18:00

YORK, Pa., Feb. 27, 2018 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (NASDAQ: XRAY ), The Dental Solutions Company™, today announced that the Company will report fourth quarter and fiscal 2017 financial [...]

AllSpire Health GPO Adopts Lumere’s Solutions to Support Value-Based Initiatives

27/02/2018 - 17:59

CHICAGO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AllSpire Health GPO, LLC—a health system alliance created to escalate the improvement of clinical outcomes, enable greater access to affordable healthcare, ensure economic [...]

Les infirmières et les infirmiers du Canada accueillent favorablement les nouvelles au sujet d’un groupe de travail national sur la mise en place d’un régime d’assurance-médicaments

27/02/2018 - 17:38

OTTAWA, 27 févr. 2018 (GLOBE NEWSWIRE) -- Les infirmières et les infirmiers du Canada accueillent favorablement les récentes nouvelles communiquées dans les médias selon lesquelles l’Honorable Eric Hoskins sera à la [...]

RAMSAY GENERALE DE SANTE : Half-year Results at the end of December 2017

27/02/2018 - 17:36

PRESS RELEASE Paris, 27 February 2018 Half-year results at the end of December 2017 Declining results in a still very negative pricing environment Published half-year turnover down 1.1% to €1,066.4 million, stable on a [...]

RAMSAY GENERALE DE SANTE : Résultats semestriels à fin décembre 2017

27/02/2018 - 17:36

COMMUNIQUE DE PRESSE Paris, le 27 Février 2018 Résultats semestriels à fin décembre 2017 Des résultats en repli dans un contexte tarifaire toujours très pénalisant Chiffre d'affaires semestriel publié en recul de 1,1% à [...]

The EMA Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in HAE Patients Aged 12 Years and Older

27/02/2018 - 17:19

The European Medicines Agency (EMA) Grants Accelerated Assessment for Shire's Lanadelumab Being Evaluated for the Prevention of Attacks in Hereditary Angioedema (HAE) Patients Aged 12 Years and Older - EMA's accelerated [...]